Merck Strategy Still Murky As Jury Mulls Vioxx Claims

Law360, New York (July 12, 2006, 12:00 AM EDT) -- For Merck & Co. to successfully defend itself against more than 13,000 lawsuits over the former blockbuster drug Vioxx, the case deliberated Wednesday by a New Jersey jury seems like a must-win.

The plaintiff in the lawsuit, Elaine Doherty, is blaming Vioxx for a heart attack she suffered in January 2004 after taking the drug for arthritis for 2 1/2 years.

Yet the 68-year-old homemaker also suffered from severely clogged arteries, obesity, high blood pressure, a cholesterol problem, a family history of heart disease and an...
To view the full article, register now.